Background Postpartum haemorrhage (PPH) is the leading cause of maternal mortality
worldwide. Prophylactic uterotonic agents can prevent PPH, and are routinely …

Background Postpartum haemorrhage (PPH) is one of the major contributors to maternal
mortality and morbidity worldwide. Active management of the third stage of labour has been …

Background Postpartum haemorrhage (PPH) is one of the major contributors to maternal
mortality and morbidity worldwide. Active management of the third stage of labour has been …

Background The routine prophylactic administration of an uterotonic agent is an integral part
of active management of the third stage of labour, helping to prevent postpartum …

Background: Postpartum hemorrhage (PPH) is a potentially fatal complication of vaginal and
cesarean deliveries. The active management of the third stage of labor provides …

Background Active management of the third stage of labour reduces the risk of postpartum
blood loss (postpartum haemorrhage (PPH)), and is defined as administration of a …

Obstetric haemorrhage, especially postpartum haemorrhage (PPH), was responsible for
more than a quarter of the estimated 303 000 maternal deaths that occurred globally in …

WHO recommendations uterotonics for the prevention of postpartum haemorrhage: web
annex 7: choice of uterotonic agents WHO recommendations Uterotonics for the prevention of …

Introduction: Postpartum hemorrhage (PPH) is one of the leading causes of maternal death
and severe maternal morbidity worldwide and strategies to prevent and treat PPH vary …

Background Administration of the uterotonic drugs is one of the main components of the
active management of the third stage of labour. The timing of uterotonics varies considerably …